【结 构 式】 |
【分子编号】11996 【品名】1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine 【CA登记号】58-96-8 |
【 分 子 式 】C9H12N2O6 【 分 子 量 】244.20416 【元素组成】C 44.27% H 4.95% N 11.47% O 39.31% |
合成路线1
该中间体在本合成路线中的序号:(III)Compound can be prepared in three different ways: 1) The reduction of cytidine (I) with H2 over Rh/Al2O3 in water in a Parr apparatus at 2.8 bar gives 3,4,5,6-tetrahydrocytidine (II), which is then hydrolyzed with water at pH 5.5. 2) The reduction of uridine (III) with H2 over Rh/Al2O3 as before gives 5,6-dihydrouridine (IV), which is then reduced again with NaBH4 in water or with H2 over Rh/Al2O3 in water containing ammonia. 3) The reduction of (III) can also be performed in a single step with H2 over Rh/Al2O3 in water containing NH3, in a Parr apparatus at 2.94 bar.
【1】 Woodman, R.J.; Tetrahydrouridine. Drugs Fut 1979, 4, 4, 283. |
【2】 Hanze, A.R.; Nucleic acids. IV. The catalytic reduction of pyrimidine nucleosides (human liver deaminase inhibitors). J Am Chem Soc 1967, 89, 25, 6720-25. |
【3】 Hanze, A.R.; Camiener, G.W.; US 3462416 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 27920 | Cytidine; 4-amino-1-((2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2(1H)-pyrimidinone | 65-46-3 | C9H13N3O5 | 详情 | 详情 |
(II) | 39509 | 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]tetrahydro-2(1H)-pyrimidinone | C9H17N3O5 | 详情 | 详情 | |
(III) | 11996 | 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine | 58-96-8 | C9H12N2O6 | 详情 | 详情 |
(IV) | 39510 | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]dihydro-2,4(1H,3H)-pyrimidinedione | C9H14N2O6 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)A new synthesis of 2',3'-dideoxyadenosine has been described: The reaction of uridine (I) with methyl orthoformate and p-toluenesulfonic acid gives the cyclic orthoester (II), which is acetylated with acetic anhydride at 100 C to the acetate (III). The reaction of (III) with acetic anhydride at temperatures over 120 C yields 5'-O-acetyl-2',3'-dideoxy-2',3'-didehydrouridine (IV), which is hydrogenated to 5'-O-acetyl-2',3'-dideoxyuridine (V).
【1】 Shiragami, H.; Shirae, H.; Irie, Y.; Yokozeki, K.; Yasuda, N.; The synthesis of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine. Nucl Acid Res Symp Ser 1988, 20, 20, 17-18. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11996 | 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine | 58-96-8 | C9H12N2O6 | 详情 | 详情 |
(I) | 12001 | 1-[(2R,5S)-5-(Hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione | 5983-09-5 | C9H12N2O4 | 详情 | 详情 |
(II) | 11997 | 1-[(3aR,4R,6R,6aR)-6-(Hydroxymethyl)-2-methoxytetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-2,4(1H,3H)-pyrimidinedione | C11H14N2O7 | 详情 | 详情 | |
(III) | 11998 | [(3aR,4R,6R,6aR)-6-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]-2-methoxytetrahydrofuro[3,4-d][1,3]dioxol-4-yl]methyl acetate | C13H16N2O8 | 详情 | 详情 | |
(IV) | 11999 | [(2S,5R)-5-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]-2,5-dihydro-2-furanyl]methyl acetate | C11H12N2O5 | 详情 | 详情 | |
(V) | 12000 | [(2S,5R)-5-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-2-furanyl]methyl acetate | C11H14N2O5 | 详情 | 详情 | |
(VI) | 12001 | 1-[(2R,5S)-5-(Hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione | 5983-09-5 | C9H12N2O4 | 详情 | 详情 |
(VII) | 10343 | 9H-Purin-6-amine; 9H-Purin-6-ylamine; Adenine | 73-24-5 | C5H5N5 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(I)2) The reaction of uridine (I) with methyl orthoformate and p-toluenesulfonic acid gives the cyclic orthoester (II), which is acetylated with acetic anhydride at 100 C, yielding the 5'-acetoxy derivative (III). The reaction of (III) with acetic anhydride at temperatures over 120 C affords 5'-O-acetyl-2',3'-dideoxy-2',3'-didehydrouridine (IV), which is hydrogenated to 5'-O-acetyl-2',3'-dideoxyuridine (V). Hydrolysis of (V) affords 2',3'-dideoxyuridine (VI), which is finally submitted to a transdideoxyribosylation with hypoxanthine (VII) by incubation in an appropriate medium with Escherichia coli AJ 2595 resting cells.
【1】 Shiragami, H.; Shirae, H.; Irie, Y.; Yokozeki, K.; Yasuda, N.; The synthesis of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine. Nucl Acid Res Symp Ser 1988, 20, 20, 17-18. |
【2】 Shirae, H.; Kobayashi, K.; Shiragami, H.; Irie, Y.; Yasuda, N.; Yokozeki, K.; Production of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine from 2',3'-dideoxyuridine and the corresponding purine bases by resting cells of Escherichia coli AJ 2595. Appl Environ Microbiol 1989, 55, 2, 419-24. |
【3】 Prous, J.; Castaner, J.; DIDEOXYINOSINE. Drugs Fut 1990, 15, 6, 569. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
60593 | p-xylene | C8H10 | 详情 | 详情 | ||
(I) | 11996 | 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine | 58-96-8 | C9H12N2O6 | 详情 | 详情 |
(II) | 11997 | 1-[(3aR,4R,6R,6aR)-6-(Hydroxymethyl)-2-methoxytetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-2,4(1H,3H)-pyrimidinedione | C11H14N2O7 | 详情 | 详情 | |
(III) | 11998 | [(3aR,4R,6R,6aR)-6-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]-2-methoxytetrahydrofuro[3,4-d][1,3]dioxol-4-yl]methyl acetate | C13H16N2O8 | 详情 | 详情 | |
(IV) | 11999 | [(2S,5R)-5-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]-2,5-dihydro-2-furanyl]methyl acetate | C11H12N2O5 | 详情 | 详情 | |
(V) | 12000 | [(2S,5R)-5-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-2-furanyl]methyl acetate | C11H14N2O5 | 详情 | 详情 | |
(VI) | 12001 | 1-[(2R,5S)-5-(Hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione | 5983-09-5 | C9H12N2O4 | 详情 | 详情 |
(VII) | 12794 | 9H-Purin-6-ol; Hypoxanthine | 68-94-0 | C5H4N4O | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(I)The acetylation of uridine (I) with acetic anhydride gives the 2',3',5'-triacetyl derivative (II), which is treated with SOCl2 and sodium ethoxide yielding the 4-ethoxypyrimidinone (III). The partial protection of (III) with 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (IV) yields the silylated compound (V), which is oxidized with oxalyl chloride to the silylated furanone (VI). The reaction of (VI) with fluoromethyl phenyl sulfone (A) by means of diethyl chlorophosphate (B) and lithium hexamethyldisylazide in THF affords the fluorovinyl sulfone (VII) as a mixture of (E) and (Z) isomers that is separated by flash chromatography. The (Z)-isomer (VII) is treated with tributyl tin hydride and AIBN in refluxing benzene to give the fluorovinyl stannane (VIII), which is finally treated with CsF and NH3 in refluxing methanol to afford the target compound.
【1】 Sunkara, P.S.; McCarthy, J.R.; Matthews, D.P.; et al.; Design of a fluoro-olefin cytidine nucleoside as a bioprecursor of a mechanism-based inhibitor of ribonucleotide reductase. ACS Symp Ser 1996, 639, 246. |
【2】 McCarthy, J.R.; et al.; Stereospecific synthesis of 1-fluoro olefins via (fluorovinyl)stannanes and an unequivocal NMR method for the assignment of fluoro olefin geometry. Tetrahedron 1996, 52, 1, 45. |
【3】 Matthews, D.P.; et al.; Improved synthesis of (E)-2'-deoxy-2'-(fluoromethylene)cytidine - A potent inhibitor of ribonucleotide diphosphate reductase. Nucleosides Nucleotides 1993, 12, 2, 115. |
【4】 McCarthy, J.R.; Edwards, M.L.; Matthews, D.P. (Merrell Pharmaceuticals, Inc.); Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivs.. EP 0372268; JP 1990178272; US 5378693 . |
【5】 McCarthy, J.R.; Matthews, D.P.; Bitonti, A.J.; Edwards, M.L. (Merrell Pharmaceuticals, Inc.); Treatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosides. US 5607925 . |
【6】 McCarthy, J.R.; Matthews, D.P.; Edwards, M.L. (Merrell Pharmaceuticals, Inc.); 2'-Ethenylidene cytidine, uridine and guanosine derivs.. US 5616702 . |
【7】 McCarthy, J.R.; et al.; Stereospecific method to E and Z terminal fluoro olefins and its application to the synthesis of 2'-deoxy-2'-fluoromethylene nucleosides as potential inhibitors of ribonucleoside diphosphate reductase. J Am Chem Soc 1991, 113, 19, 7439. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(B) | 23623 | Chlorophosphoric acid ethyl ester;Phosphorochloridic acid diethyl ester;Diethyl chlorophosphate;diethyl phosphorochloridate | 814-49-3 | C4H10ClO3P | 详情 | 详情 |
(A) | 29245 | (fluoromethyl)(dioxo)phenyl-lambda(6)-sulfane | 20808-12-2 | C7H7FO2S | 详情 | 详情 |
(I) | 11996 | 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine | 58-96-8 | C9H12N2O6 | 详情 | 详情 |
(II) | 29248 | (2R,3R,4R,5R)-4-(acetoxy)-2-[(acetoxy)methyl]-5-[2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl]tetrahydro-3-furanyl acetate | C15H18N2O9 | 详情 | 详情 | |
(III) | 29249 | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-4-ethoxy-2(1H)-pyrimidinone | C11H16N2O6 | 详情 | 详情 | |
(IV) | 29242 | 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane | 69304-37-6 | C12H28Cl2OSi2 | 详情 | 详情 |
(V) | 29250 | 1-[(6aR,8R,9R,9aS)-9-hydroxy-2,2,4,4-tetraisopropyltetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-4-ethoxy-2(1H)-pyrimidinone | C23H42N2O7Si2 | 详情 | 详情 | |
(VI) | 29251 | 1-[(6aR,8R,9aR)-2,2,4,4-tetraisopropyl-9-oxotetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-4-ethoxy-2(1H)-pyrimidinone | C23H40N2O7Si2 | 详情 | 详情 | |
(VII) | 29252 | 1-[(6aR,8R,9aS)-9-[(Z)-fluoro(phenylsulfonyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-ethoxy-2(1H)-pyrimidinone | C30H45FN2O8SSi2 | 详情 | 详情 | |
(VIII) | 29253 | 1-[(6aR,8R,9aS)-9-[(Z)-fluoro(tributylstannyl)methylidene]-2,2,4,4-tetraisopropyldihydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8(8H)-yl]-4-ethoxy-2(1H)-pyrimidinone | C36H67FN2O6Si2Sn | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号:(IV)INS-365 can also been obtained by the following ways: 4) Dimerization of uridine-5'-monophosphate tributyl-ammonium salt (I) with bis(tributylammonium) pyrophosphate (II) by means of CDI, followed by purification by semipreparative ionexchange chromatography. 5) Dimerization of uridine-5'-monophosphate tributyl-ammonium salt (I) with pyrophosphoryl chloride (III) in pyridine, followed by chromatographic purification as before. 6) Condensation of uridine (IV) with POCl3 and bis(tributylammonium) pyrophosphate (II) by means of tributylamine in trimethyl phosphate, followed by chromatographic purification as before. 7) Dimerization of uridine-5'-diphosphate tributylammonium salt (V) by means of CDI in DMF, followed by purification over Dowex 50Wx4 Na+. 8) Condensation of uridine-5'-triphosphate tributylammonium salt (VI) with uridine-5'-monophosphate tributyl-ammonium salt (I) by means of DCC in DMF, followed by chromatographic purification as before. 9) Reaction of uridine-5'-monophosphate tributylammonium salt (I) with CDI in DMF, followed by condensation with uridine-5'-triphosphate (VI) and chromatographic purification as before.
【1】 Yerxa, B.J.; Pendergast, W. (Inspire Pharmaceuticals, Inc.); Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof. JP 2001510484; WO 9905155 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 47688 | C21H40N3O9P | 详情 | 详情 | ||
(II) | 47695 | di(N,N-dibutyl-1-butanaminium) 1,3-dihydroxy-1,3-dioxo-1lambda(5),3lambda(5)-diphosphoxane-1,3-diolate | C24H58N2O7P2 | 详情 | 详情 | |
(III) | 47694 | Pyrophosphoric tetrachloride | Cl4O3P2 | 详情 | 详情 | |
(IV) | 11996 | 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine | 58-96-8 | C9H12N2O6 | 详情 | 详情 |
(V) | 47690 | C33H68N4O12P2 | 详情 | 详情 | ||
(VI) | 47692 | C45H96N5O15P3 | 详情 | 详情 |
合成路线6
该中间体在本合成路线中的序号:(I)
【1】 Krmitsky TA. 1988. Antiviral compounds. EP 0294114[本专利为GlaxoSmithKline (GB)所有] |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11996 | 1-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione; Uridine | 58-96-8 | C9H12N2O6 | 详情 | 详情 |
(II) | 66535 | (2R,3S,3aS,9aR)-3-hydroxy-2-(hydroxymethyl)-3,3a-dihydro-2H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6(9aH)-one | C9H10N2O5 | 详情 | 详情 | |
(III) | 38235 | 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]-2,4(1H,3H)-pyrimidinedione | C9H12N2O6 | 详情 | 详情 |